Arkolith/Insider Trading/ANEB/Form 4

22NW, LP

10% OwnerAnebulo Pharmaceuticals, Inc. (ANEB) · full profile →Form 4 · filed May 7, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2021Grant(A)714K$7.00$5.0M3.3M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-010808) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML